TDGF1/CRIPTO Human Monoclonal Antibody
Anti-Human TDGF1/CRIPTO (BDKKD237) is a research-grade recombinant antibody targeting Cripto-1 growth factor. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Cripto-1 growth factor, Teratocarcinoma-derived growth factor 1, TDGF1, CRIPTO, Epidermal growth factor-like cripto protein CR1, CRGF
UniProt
P13385
Reactivity
Human
Clonality
Monoclonal
Clone
BDKKD237
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
FPRL2 (Formyl Peptide Receptor-like 2, FMLP-related Receptor II, FMLP-R-II, N-formyl Peptide Receptor 3, FPR3, FPRH1) (APC)
FPRL2 (Formyl Peptide Receptor-like 2, FMLP-related Receptor II, FMLP-R-II, N-formyl Peptide Receptor 3, FPR3, FPRH1) (APC)
